1571 |
LAA Closure with AMULET and LAmbre Device |
Cheung Chi Simon Lam |
Apr. 20. 23 |
1570 |
Current Status and Future Perspectives of LAA Closure |
Min Soo Cho |
Apr. 20. 23 |
1569 |
Temporal Trends in TAVR Indication and Outcomes - Insights from the US TVT Registry |
David Joel Cohen |
Apr. 20. 23 |
1568 |
Hostile Femoral Access in Patients Undergoing TAVR: What¡¯s the Best Choice? |
Kentaro Hayashida |
Apr. 20. 23 |
1567 |
Neurocognitive Trajectory Following TAVR |
Mao-Shin Lin |
Apr. 20. 23 |
1566 |
ACURATE NEO 2 |
Young-Guk Ko |
Apr. 20. 23 |
1565 |
EVOLUT: New Trials, New Technologies (OPTIMIZE PRO and SMART) |
Eberhard Grube |
Apr. 20. 23 |
1564 |
SAPIEN: Simpler and More Sophisticated (X4 and ALLIANCE) |
Duk-Woo Park |
Apr. 20. 23 |
1563 |
Complication Case Presentation 5 |
Aaron Hean Jin Ong |
Apr. 20. 23 |
1562 |
Complication Case Presentation 4 |
Chandan Deepak Bhavnani |
Apr. 20. 23 |